Exscientia
design flaws can impact clinical outcomes | Exscientia
Company
Deck Type
IPO
Sector
Industry
Deck date
September 2021
Slide
28 of 60
Similar slides by Exscientia
See diffirences between slides (animation)
Investor Presentation
March 2024
our candidate resolves critical design issues | Exscientia
Results
March 2024
safety is critical differentiation for the mechanism | Exscientia
Investor Day
January 2024
our candidate resolves critical design issues | Exscientia
Investor Presentation
November 2023
our candidate resolves critical design issues | Exscientia
Related slides by other companies
Absci
Investor Presentation
July 2023
antibodies selected in tertiary lymphoid structures bind to cancer cells and are associated with favorable clinical outcomes | Absci
Talkspace
SPAC
January 2021
science based approach leads to superior clinical outcome talk space | Talkspace
Absci
Investor Presentation
March 2023
antibodies selected in tertiary lymphoid structures bind to cancer cells and are associated with favorable clinical outcomes go | Absci
Recursion Pharmaceuticals
Investor Day
January 2023
clinical orally small molecule inhibitor disease state impact blocks mutation induced signaling are | Recursion Pharmaceuticals
Other recent decks by Exscientia
See all presentations (14 decks)
Investor Presentation
March 2024
Results
March 2024
Investor Day
January 2024
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io